TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/9/24 16:30 | 8/8/24 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taylor Daphne | WA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 0 | 38 | 1 | D | ||||||||||||||
3/5/24 16:13 | 3/2/24 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taylor Daphne | WA | O | SVP,CFO | M.dm | 0 | 0.00 | 0 | 5 | 40 | 18 | D | ||||||||||||||
1/30/24 18:05 | 1/29/24 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taylor Daphne | WA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 6 | 13 | D | ||||||||||||||
8/10/23 08:47 | 8/8/23 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taylor Daphne | WA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 7 | 128 | 12 | D | ||||||||||||||
3/7/23 16:41 | 3/4/23 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taylor Daphne | WA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 2 | 41 | 5 | D | ||||||||||||||
3/10/09 18:12 | 3/7/09 | CSCX | Cardiac Science Corp | Health | MdEq | Surgical & Medical Instrument | Taylor Daphne L | WA | O | VP,Chief | M.d | 0 | 0.00 | 0 | 2 | 1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |